Skip to content

LYNX PHARMA

Dissolved and wound up on 12-07-2023 KBO/BCE: BE 0686.797.810
LYNX PHARMA
Follow Report

Board mandates elsewhere

1 board mandate
Board mandates of LYNX PHARMALYNX PHARMA sits on their board1
Director
Founded in 2013 · turnover €96.9m (2025)

Connections & network

Depth

The board mandates are listed under Board mandates elsewhere. The network lets you explore the same ties.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

We would like to set cookies. That happens only with your consent. What we measure